Wells Fargo’s HUMANIGEN, INC. HGEN Stock Holding History

Wells Fargo’s Portfolio HGEN Stock Details HGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,780	Closed	-$576	–	7786
2023 Q2	$576	Buy	3,780 +31	+0.8%	+$5	﹤0.01%	6453
2023 Q1	$538	Buy	3,749 +107	+3%	+$17	﹤0.01%	6538
2022 Q4	$437	Buy	3,642 +16	+0.4%	+$2	﹤0.01%	6421
2022 Q3	$1K	Buy	3,626 +267	+8%	+$144	﹤0.01%	6538
2022 Q2	$6K	Sell	3,359 -10,645	-76%	-$23.9K	﹤0.01%	5967
2022 Q1	$42K	Sell	14,004 -17,011	-55%	-$45.5K	﹤0.01%	5740
2021 Q4	$115K	Buy	31,015 +6,404	+26%	+$37.5K	﹤0.01%	5563
2021 Q3	$147K	Buy	24,611 +20,936	+570%	+$294K	﹤0.01%	5225
2021 Q2	$64K	Buy	3,675 +673	+22%	+$12.3K	﹤0.01%	5464
2021 Q1	$57K	Sell	3,002 -21,317	-88%	-$389K	﹤0.01%	5756
2020 Q4	$426K	Buy	+24,319	New	+$291K	﹤0.01%	4635

Other funds holding HGEN

TCM

Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return

DWP

Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Wells Fargo's HGEN Position: Q3 2023 in Review

Wells Fargo sold out of HUMANIGEN, INC. (HGEN) in Q3 2023, closing a stake of 3,780 shares — an estimated $576 sold.

Wells Fargo first reported a position in HGEN in Q4 2020 and held it in 11 quarters. The position peaked at $426K in Q4 2020. 3 funds tracked by Wall St. Rank hold HGEN as of Q3 2023.

Wells Fargo reported no remaining HUMANIGEN, INC. position as of Q3 2023 after selling out during the quarter.
Wells Fargo sold 3,780 HUMANIGEN, INC. shares in Q3 2023, an estimated $576.
Wells Fargo first reported a position in HUMANIGEN, INC. in Q4 2020 and held it in 11 quarters.
Wells Fargo's HUMANIGEN, INC. position peaked at $426K in Q4 2020.
3 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q3 2023.

Based on Wells Fargo's 13F filing for Q3 2023, filed 13 Nov 2023.